Current status and future perspective of radiopharmaceuticals in China.

Eur J Nucl Med Mol Imaging · 2022 · PMC8586637 · PMID 34767047

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

However, the radiopharmaceuticals currently in clinical application in China are mainly generic drugs, and the gap compared with developed countries is still quite significant, especially in the area of research and development and clinical translation of therapeutic radiopharmaceuticals.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.